ArticlePhysics and imaging in radiation oncology2025
Individualised dose mapping uncertainty estimation in the reirradiation setting.
Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Deformable image registration (DIR) allows assessing radiation doses of previous treatment courses in reirradiation planning scans. However, DIR can introduce uncertainties in dose mapping. Estimating these uncertainties for individual patients remains a key challenge. We developed an individualised approach to estimate uncertainties in dose mapping using a commercially available treatment planning system. Materials and methods: For 54 patients who underwent reirradiation (27 head and neck, H&N, and 27 lung cases), we performed 16 DIRs per patient. We assessed each DIR geometrically using the mean distance to agreement (mDTA) between mapped contours and the corresponding structures of 30 to 34 organs at risk (OARs). We then estimated dose mapping uncertainties for structures where DIR resulted in plausible registrations, defined as mDTA ≤ 0.3 cm. We calculated the uncertainty of dose-volume-histogram estimates (mean and D0.1 cm Results: DIR resulted in plausible mappings for both patient cohorts' OARs, ranging between 78.6 % and 88.2 %, varying between patients and OARs. Mean dose uncertainties ranged between 0 Gy and 0.43 Gy, while larger differences were observed for D0.1 cm3, between 0 Gy and 0.78 Gy. As expected, large voxel-wise uncertainties were in regions of steep dose gradients. Performance between registration sets was similar. Conclusion: We developed a method to estimate dose mapping uncertainties with integrated quality control for reirradiation. Differences between patients were observed, justifying the need for individualised DIR assessment. Few registrations were a pragmatic approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.